Closed · RFA-DP-19-003 · CFDA 93.283 · Discretionary

Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts

Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.

$700K-$1M
Award range
Closed
Status
March 8, 2019
Close date
4
Expected awards

The verdict

Epidemiology of Lupus: Longitudinal Studies in Population-Based Cohorts is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $700,000 -- $1,000,000 across 4 expected awards. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.

$700K-$1M
award range
Closed
application status
4
expected awards
93.283
CFDA program

Archived opportunity record

Epidemiology of Lupus: Longitudinal Studies i… is closed (last close March 8, 2019). The parent program page for CFDA 93.283 is the reliable place to catch re-announcements. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed March 8, 2019

Posted Jan 4 Closes Mar 8

Est. Total Funding

$10,500,000

Expected Awards

4

Instrument

Cooperative Agreement

Description

This NOFO is intended to support research on lupus through a 2-component cooperative agreement:Component A (Longitudinal Studies in Population-based Cohorts of Adults with Lupus: 3 Year Followup):This is a longitudinal followup study designed to support an established, US-based, population-based cohort of adults age 18 and older with diagnosed lupus (systemic lupus erythematosus {SLE} and skin lupus) that includes followup data collected at least once since 2015. The intent of this study is to conduct data collection, building upon the cohort and initial followup activities. This data collection should include four content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that adults with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.Component B: (A Pediatric Lupus Registry with Longitudinal Follow up):This is a project that will support an existing US-based registry of children age 0-17 years with diagnosed lupus (SLE and skin lupus). The intent of this study is to gather baseline data for children age 0-17 years and follow up data for this cohort for three additional years. The baseline and follow up data should include these 4 content areas:The natural history (e.g., severity, morbidity, mortality, disability, comorbidity, work interference, etc.) of cohort members, andTreatment (e.g., medications, therapy, self-management, etc.) of lupus including the treatment of chronic pain and opioid use, andHealth care access and gaps that children with lupus experience, andDisparities (e.g., age, race/ethnicity, sex) and other factors associated with lupus outcomes.

Wide-open applicant board · 16 Grants.gov doors

Epidemiology of Lupus: Longitudinal Studies i… prints 16 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +12 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). 65 other Centers for Disease Control and Prevention - ERA listings share this eligibility-code string (10% of 640).

Code 00
State governments
Code 01
County governments
Code 02
City or township governments
Code 04
Special district governments
Code 05
Independent school districts
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 22
For-profit organizations other than small businesses
Code 23
Small businesses
Code 25
Others (see official listing text)
Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Jessie Hood jvr4@cdc.gov

What to do next

Epidemiology of Lupus: Longitudinal Studies i… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.283 may publish future NOFOs under the same assistance listing. Open program
  • Centers for Disease Control Investigations an… indexes 3 Grants.gov listings in this extract. Program profile
  • Centers for Disease Control and Prevention - ERA lists 639 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants